151763-75-6

Basic information

• Product Name: ETHYL (R)-3-HYDROXY-TETRADECANOATE
• Synonyms: TETRADECANOIC ACID, 3-HYDROXY-, ETHYL ESTER, (R);ETHYL (R)-3-HYDROXY-TETRADECANOATE
• CAS NO: 151763-75-6
• Molecular Formula: C₁₆H₃₂O₃
• Molecular Weight: 272.42
• Mol File: 151763-75-6.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 374.2±15.0 °C(Predicted)
• Appearance: /
• Density: 0.926±0.06 g/cm3(Predicted)
• PKA: 14.41±0.20(Predicted)
• CAS DataBase Reference: ETHYL (R)-3-HYDROXY-TETRADECANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL (R)-3-HYDROXY-TETRADECANOATE(151763-75-6)
• EPA Substance Registry System: ETHYL (R)-3-HYDROXY-TETRADECANOATE(151763-75-6)

Safety Data

• Hazardous Substances Data: 151763-75-6(Hazardous Substances Data)

Upstream product

• 112-54-9 Dodecanal 
• 335153-25-8 (E)-Tetradec-2-enoic acid ethyl ester 
• 112-29-8 1-bromo dodecane 
• 17049-50-2 n-decyl magnesium bromide 
• 112083-63-3 ethyl (-)-(2S)-oxirane-2-acetate 
• 74124-22-4 ethyl 3-oxotetradecanoate 
• 112100-39-7 (S)-4-iodo-3-hydroxy-butyric acid ethyl ester 
• 141-97-9 ethyl acetoacetate 

Downstream Products

• 87357-65-1 (3R)-3-hydroxytetradecanoic acid phenacyl ester 
• 339316-63-1 (R)-3-Dodecanoyloxy-tetradecanoic acid 2-oxo-2-phenyl-ethyl ester 
• 91681-56-0 (3R)-3-dodecanoyloxytetradecanoic acid 
• 87357-66-2 phrnacyl (R)-3-(benzyloxy)tetradecanoate 
• 87357-67-3 (R)-3-benzyloxytetradecanoic acid 
• 68711-40-0 (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 
• 104872-04-0 Orlistat 
• 28715-21-1 (R)-3-hydroxytetradecanoic acid 

Relevant articles and documents

BIFUNCTIONAL COMPOUND AND ITS USE IN IMMUNOTHERAPY

The invention relates to a bifunctional compound that is, on one side, an agonist of the TLR4 and, on the other side, an important inhibitor of the PSMA. Said compound is useful in immunotherapy for the treatment and/or prevention of prostate cancer. Therefore, the invention also relates to the use of the compound and to the pharmaceutical composition comprising it.

BETA-LACTONE COMPOUNDS

The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group consisting of an alkyl, an alkenyl, an aryl, a heterocycle, hydroxyl, ester, amido, aldehyde, and a halogen.

Highly enantioselective hydrogenation of β-alkyl and β-(ω-chloroalkyl) substituted β-keto esters

Highly enantioselective hydrogenation of β-alkyl and β-(ω-chloroalkyl) substituted β-keto esters was achieved with Ru catalysts based on chiral diphosphines in EtOH at 50°C under 50-bar initial hydrogen pressure, affording the corresponding β-hydroxy esters in >98% ee. Copyright Taylor & Francis Group, LLC.